News

Back
December 10, 2020

Salarius Pharmaceuticals Receives First Installment of $1.7 Million in Payments from the Cancer Prevention and Research Institute of Texas

Contact

Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com
Download PDF